SRC and non-small cell lung carcinoma: Having observed that the inhibition of SRC/FAK signaling in H358-S and other NSCLC cells leads to decreased invasive ability, we sought to study the effects of these inhibitors on erlotinib sensitivity of smoke-exposed cells.